ACADIA Pharmaceuticals Inc (ACAD)

ACADIA Pharmaceuticals Inc (ACAD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.5B; returns 1 day -2.9%, 1 week +3.2%, 1 year -9.2%.

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for neurological and rare diseases.

Groups ACAD belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• Neuroscience
• Neurological Disorders
• Rare Diseases
• Commercial Stage Biotech
• Rett Syndrome
• Pharmaceuticals
• CNS Disorders
• Alzheimer's Disease
• Life Sciences

ACAD financial model: income statement, cash flow and balance sheet